Voyager Therapeutics, Inc. (VYGR)

Voyager Therapeutics Revenue

Voyager Therapeutics had revenue of $5.20M in the quarter ending June 30, 2025, a decrease of -82.42%. This brings the company's revenue in the last twelve months to $42.58M, down -70.38% year-over-year. In the year 2024, Voyager Therapeutics had annual revenue of $80.00M, down -68.00%.

• Revenue (ttm): $42.58M
• Revenue Growth: -70.38%
• P/S Ratio: 5.09
• Revenue / Employee: $247,558
• Employees: 172
• Market Cap: 209.12M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	80.00M	-170.01M	-68.00%
Dec 31, 2023	250.01M	209.10M	511.16%
Dec 31, 2022	40.91M	3.49M	9.33%
Dec 31, 2021	37.42M	-133.71M	-78.14%
Dec 31, 2020	171.13M	66.74M	63.93%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.